Available data types
Over the past two decades, thousands of molecular measurements have been generated from the NCI-60 cell lines, including:
- Transcriptomics:
- RNA-Seq
- DNA microarrays
- Genomics:
- Single Nucleotide Polymorphisms (SNPs)
- Copy Number Variants (CGH)
- Proteomics:
- Protein expression
- Enzyme activities
- Epigenetics:
- DNA methylation
- miRNA profiling
- Metabolomics and Mutation Data
These data were generated through collaborative studies via the DTP Molecular Targets Program and are continually updated.
Access DTP Molecular Targets Data
Apply to Measure New Molecular Targets
Investigators may apply to perform additional molecular profiling on the NCI-60 panel using DTP-provided materials. This collaborative program supports the discovery of drug-target relationships, biomarkers, or mechanistic correlates.
What's Provided
- Frozen cell pellets (typically 1×10⁷ cells)
- Possible access to other NCI-60 materials (pending request)
- Data analysis support (optional)
- Option to link results with HTS384/COMPARE data
Application Requirements
Please complete and submit via email to moltarget@mail.nih.gov:
An application form for material support to undertake the measurement of molecular targets.
Applicants must also complete a standard Material Transfer Agreement (MTA) which includes an agreement that they will return finalized data to DTP for public release, after an embargo period.
Integrating with Screening & COMPARE
Molecular target data can be:
- Used alongside HTS384 screening data to explore target-sensitivity correlations
- Integrated with COMPARE analysis to uncover potential shared mechanisms
- Mined to identify tumor subpanel-selective biomarkers (e.g., colon vs. melanoma)
Use case: Identify genes whose expression correlates with a compound’s GI50 pattern across the NCI-60.
Cell Line Reclassifications (Based on Molecular Profiling)
Recent omics studies led to updates in lineage assignments of certain NCI-60 lines:
- MDA-MB-435 & MDA-N → melanoma, not breast cancer
- NCI/ADR-RES → ovarian, not breast cancer
- SNB-19 & U251 → derived from the same CNS tumor
These changes are based on consistent evidence from:
- Gene expression profiling
- SNP and CGH array data
- DNA fingerprinting and karyotype comparisons
Full details and citations are available here.
Tools & Resources